P PRIMESTOCKFINDER.COM

MEC Shares Morphic Ethical Equities Fund Limited

WATCH ASX · ASX
$1.13 +0.00% Prices as of close 2026-10-27

Energy-transition mineral exposure may benefit from improving critical-minerals sentiment.

  • ▸Exploration updates could attract speculative institutional interest.
  • ▾Below 50-day MA (-5.13%)
  • ▾Near 52-week low (13.3% of range)

Trend: MEC is trading below the 50-day average (-5.04%), RSI 61 — neutral momentum, with a 3-month return of -11.02%.

Valuation & quality: Morphic Ethical Equities Fund Limited trades on a trailing P/E of 4.9; fundamentals show net margin 0.0%.

Income: trailing dividend yield 4.96%.

Our screen: WATCH (score 0) — Energy-transition mineral exposure may benefit from improving critical-minerals sentiment.

Computed from end-of-day data; not personal advice.

1.39 1.11 FebMarAprMayJunJulAugSepOct
Daily close, 2026-02-08 → 2026-10-25 (AUD). Range 1.11 – 1.39.
Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
-7.50%+9.00%+6.60%+3.90%-8.20%-2.40%-1.70%-4.20%
Market cap
$33.8M
P/E (ttm)
4.9
EPS (ttm)
$0.23
Net margin
0.0%
Dividend yield
4.96%
52-wk range
$1.09 – $1.39
Volume
997
Avg volume (3m)
5,337
RSI (14)
60.8
vs 50-day MA
-5.04%
1-mo return
-3.83%
3-mo return
-11.02%
Volume z-score
-0.55

Morphic Ethical Equities Fund Limited is an equity mutual fund launched and managed by Morphic Asset Management Pty Limited. The fund invests in public equity markets across the globe. It also invests in derivatives. The fund invests in stocks of companies across diversified market capitalizations.

Sector: Financial Services · Industry: Asset Management · Australia · Website

Browse: all ASX stocks · Energy picks · today's movers

General information only (Australia). This is general information, not financial product advice. It doesn't consider your objectives, financial situation or needs — consider its appropriateness and seek licensed advice before acting. Not a recommendation to buy or sell any financial product.

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.